Advanced Therapeutics SynaptaLean Rx-Fat Loss
On sale on the US market (according to the DSLD)
NaturesPlus, food supplement from the US market
Advanced Therapeutics SynaptaLean Rx-Fat Loss (NaturesPlus), a food supplement au code-barres 097467049901, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 21 mg a day according to the label (at most 1 serving a day), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Chrome: up to 133 µg a day according to the label (at most 1 serving a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- À vérifier
Vitamine B6: up to 21 mg a day according to the label, above the tolerable upper intake level from EFSAEuropean Food Safety Authority. for adults (12 mg a day). The EFSA reference covers total daily intake, from food and supplements.
Source: EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), limite supérieure de sécurité (UL).
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- NaturesPlus
- Barcode
- 097467049901
- Form
- Tablet
- One serving
- 2 tablets
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Magnesium Stearate, Cellulose, Stearic Acid, Silica, Hydroxypropyl Methylcellulose, Pharmaceutical Glaze
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Thiamine | Vitamin | 30 mg |
| Vitamin B6 | Vitamin | 21 mg |
| Chromium | Mineral | 133 µg |
| SynaptaLean Neuronutrient Complex | Blend | 3,771 mg |
| Synaptose | Blend | not stated |
| D-PhenEze | Amino acid | not stated |
| L-Tyrosine | Amino acid | not stated |
| Passion Flower extract (Passiflora incarnata) | Plant | not stated |
| Metallosaccharide Complex | Blend | not stated |
| RhodiGen | Plant | not stated |
| L-Glutamine | Amino acid | not stated |
| 5-HTP | Amino acid | not stated |
| Thiamine Hydrochloride | Vitamin | not stated |
| Pyridoxal 5-Phosphate | Vitamin | not stated |
| Pyridoxine Hydrochloride | Vitamin | not stated |
| ChromeMate | Mineral | not stated |
| Full Spectrum Whole Food Blend | Blend | 99 mg |
| Green Whole Food Blend | Blend | not stated |
| White Whole Food Blend | Blend | not stated |
| Yellow Whole Food Blend | Blend | not stated |
| Red Whole Food Blend | Blend | not stated |
| Blue Whole Food Blend | Blend | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Advanced Therapeutics SynaptaLean Rx-Fat Loss
Entered into DSLD on 25 April 2019. Withdrawn from the US market on 28 February 2022 (according to the DSLD).- Active ingredient added : Aloe barbadensis (quantity not stated)
- Active ingredient added : Anti-Aging Red Whole Food Blend (quantity not stated)
- Active ingredient added : Astragalus membranaceous (quantity not stated)
- Active ingredient added : Boswellia (quantity not stated)
- Active ingredient added : Brain Support Blue Whole Food Blend (quantity not stated)
- Active ingredient added : Chromium Polynicotinate (quantity not stated)
- Active ingredient added : Defense and Repair Yellow Whole Food Blend (quantity not stated)
- Active ingredient added : DL-Phenylalanine (quantity not stated)
- Active ingredient added : Energizing and Cleansing Green Whole Food Blend (quantity not stated)
- Active ingredient added : Larix occidentalis extract (quantity not stated)
- Active ingredient added : N-Acetyl Glucosamine (quantity not stated)
- Active ingredient added : N-Acetyl Glucosamine (quantity not stated)
- Active ingredient added : P5P (quantity not stated)
- Active ingredient added : Pine bark extract (quantity not stated)
- Active ingredient added : Rhodiola rosea (quantity not stated)
- Active ingredient added : Spirulina (quantity not stated)
- Active ingredient added : Strength and Endurance White Whole Food Blend (quantity not stated)
- Active ingredient added : Synaptamine (quantity not stated)
- Active ingredient added : Zehntose (quantity not stated)
- Active ingredient removed : Blue Whole Food Blend (quantity not stated)
- Active ingredient removed : ChromeMate (quantity not stated)
- Active ingredient removed : D-PhenEze (quantity not stated)
- Active ingredient removed : Green Whole Food Blend (quantity not stated)
- Active ingredient removed : Pyridoxal 5-Phosphate (quantity not stated)
- Active ingredient removed : Red Whole Food Blend (quantity not stated)
- Active ingredient removed : RhodiGen (quantity not stated)
- Active ingredient removed : White Whole Food Blend (quantity not stated)
- Active ingredient removed : Yellow Whole Food Blend (quantity not stated)
- Quantity stated differently, without estimation : Chromium: 133 mcg ; 400 mcg in this version; 133 mcg ; 399 mcg on the displayed label
- Quantity stated differently, without estimation : Full Spectrum Whole Food Blend: 100 mg ; 33 mg in this version; 33 mg ; 99 mg on the displayed label
- Quantity stated differently, without estimation : SynaptaLean Neuronutrient Complex: 1,257 mg ; 3,770 mg in this version; 1,257 mg ; 3,771 mg on the displayed label
- Quantity stated differently, without estimation : Thiamine: 10 mg ; 31 mg in this version; 10 mg ; 30 mg on the displayed label
- Quantity stated differently, without estimation : Vitamin B6: 20 mg ; 7 mg in this version; 21 mg ; 7 mg on the displayed label
Official label: Advanced Therapeutics SynaptaLean Rx-Fat Loss
Entered into DSLD on 23 December 2016. Withdrawn from the US market on 11 June 2018 (according to the DSLD).- Active ingredient added : 5-HTP (quantity not stated)
- Active ingredient added : Anti-Aging Red Whole Food Blend (quantity not stated)
- Active ingredient added : Anti-Aging Red Whole Food Blend (quantity not stated)
- Active ingredient added : Brain Support Blue Whole Food Blend (quantity not stated)
- Active ingredient added : Brain Support Blue Whole Food Blend (quantity not stated)
- Active ingredient added : Chromium (quantity not stated)
- Active ingredient added : Chromium (quantity not stated)
- Active ingredient added : Defense and Repair Yellow Whole Food Blend (quantity not stated)
- Active ingredient added : Defense and Repair Yellow Whole Food Blend (quantity not stated)
- Active ingredient added : DL-Phenylalanine (quantity not stated)
- Active ingredient added : DL-Phenylalanine (quantity not stated)
- Active ingredient added : Energizing and Cleansing Green Whole Food Blend (quantity not stated)
- Active ingredient added : Energizing and Cleansing Green Whole Food Blend (quantity not stated)
- Active ingredient added : L-Glutamine (quantity not stated)
- Active ingredient added : L-Tyrosine (quantity not stated)
- Active ingredient added : Metallosaccharide Complex (quantity not stated)
- Active ingredient added : P5P (quantity not stated)
- Active ingredient added : P5P (quantity not stated)
- Active ingredient added : Passion Flower (quantity not stated)
- Active ingredient added : Passion Flower (quantity not stated)
- Active ingredient added : Pyridoxine Hydrochloride (quantity not stated)
- Active ingredient added : Rhodiola rosea (quantity not stated)
- Active ingredient added : Rhodiola rosea (quantity not stated)
- Active ingredient added : Strength and Endurance White Whole Food Blend (quantity not stated)
- Active ingredient added : Strength and Endurance White Whole Food Blend (quantity not stated)
- Active ingredient added : Synaptose Neuronutrient Complex (1,257 mg ; 3,770 mg)
- Active ingredient added : Thiamine Hydrochloride (quantity not stated)
- Active ingredient removed : Blue Whole Food Blend (quantity not stated)
- Active ingredient removed : ChromeMate (quantity not stated)
- Active ingredient removed : D-PhenEze (quantity not stated)
- Active ingredient removed : Green Whole Food Blend (quantity not stated)
- Active ingredient removed : Passion Flower extract (quantity not stated)
- Active ingredient removed : Pyridoxal 5-Phosphate (quantity not stated)
- Active ingredient removed : Red Whole Food Blend (quantity not stated)
- Active ingredient removed : RhodiGen (quantity not stated)
- Active ingredient removed : SynaptaLean Neuronutrient Complex (1,257 mg ; 3,771 mg)
- Active ingredient removed : Synaptose (quantity not stated)
- Active ingredient removed : White Whole Food Blend (quantity not stated)
- Active ingredient removed : Yellow Whole Food Blend (quantity not stated)
- Quantity stated differently, without estimation : Chromium: 133 mcg ; 400 mcg in this version; 133 mcg ; 399 mcg on the displayed label
- Quantity stated differently, without estimation : Full Spectrum Whole Food Blend: 100 mg ; 33 mg in this version; 33 mg ; 99 mg on the displayed label
- Quantity stated differently, without estimation : Thiamine: 10 mg ; 31 mg in this version; 10 mg ; 30 mg on the displayed label
- Quantity stated differently, without estimation : Vitamin B6: 20 mg ; 7 mg in this version; 21 mg ; 7 mg on the displayed label
Official label: Advanced Therapeutics SynaptaLean Rx-Fat Loss
Entered into DSLD on 21 November 2012. Withdrawn from the US market on 31 October 2016 (according to the DSLD).- Active ingredient added : 5-Hydroxytryptophan (quantity not stated)
- Active ingredient added : Chromium Polynicotinate (quantity not stated)
- Active ingredient added : DL-Phenylalanine (quantity not stated)
- Active ingredient added : Passion Flower (quantity not stated)
- Active ingredient added : Rhodiola rosea (quantity not stated)
- Active ingredient added : Synaptose Neuronutrient Complex (1,257 mg ; 3,770 mg)
- Active ingredient removed : 5-HTP (quantity not stated)
- Active ingredient removed : Blue Whole Food Blend (quantity not stated)
- Active ingredient removed : ChromeMate (quantity not stated)
- Active ingredient removed : D-PhenEze (quantity not stated)
- Active ingredient removed : Green Whole Food Blend (quantity not stated)
- Active ingredient removed : Passion Flower extract (quantity not stated)
- Active ingredient removed : Red Whole Food Blend (quantity not stated)
- Active ingredient removed : RhodiGen (quantity not stated)
- Active ingredient removed : SynaptaLean Neuronutrient Complex (1,257 mg ; 3,771 mg)
- Active ingredient removed : Synaptose (quantity not stated)
- Active ingredient removed : White Whole Food Blend (quantity not stated)
- Active ingredient removed : Yellow Whole Food Blend (quantity not stated)
- Quantity stated differently, without estimation : Chromium: 133 mcg ; 400 mcg in this version; 133 mcg ; 399 mcg on the displayed label
- Quantity stated differently, without estimation : Full Spectrum Whole Food Blend: 100 mg ; 33 mg in this version; 33 mg ; 99 mg on the displayed label
- Quantity stated differently, without estimation : Thiamine: 10 mg ; 31 mg in this version; 10 mg ; 30 mg on the displayed label
- Quantity stated differently, without estimation : Vitamin B6: 20 mg ; 7 mg in this version; 21 mg ; 7 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Passion Flower extract
Read the warning, when it applies and the studies cited
PASSIONFLOWER -PASSIFLORA INCARNATA
Route of administration: Oral
Cautions and warnings
Condition of application: Sleep aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Berardi et al. 2002: DiPiro et al. 2002).
Sources cited by Health Canada (2)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiological Approach, 5th edition. New York (NY): McGraw-Hill Co. Inc.; 2002
Condition of application: Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product avoid taking with alcohol or products that cause drowsiness (EMA 2014; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
- L-Glutamine
Read the warning, when it applies and the studies cited
L-Glutamine
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- 5-HTP
Read the warning, when it applies and the studies cited
5-HTP
Route of administration: Oral
Cautions and warnings
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking carbidopa or health products with serotonergic activity such as mood balance supplements, cough medication containing dextromethorphan, pain killers or medications for nausea or migraine (Mayo Clinic Staff 2022; Patel and Marzella 2017; Turner et al 2006).
Sources cited by Health Canada (3)
- Mayo Clinic Staff. Serotonin Syndrome. Rochester (MN): Mayo Foundation for Medical Education and Research; 2022. [Accessed 2023 March 07]. Available from: https://www.mayoclinic.org/diseases-conditions/serotonin-syndrome/symptoms-causes/syc-20354758.
- Patel YA, Marzella N. Dietary supplement-drug interaction-induced serotonin syndrome progressing to acute compartment syndrome. American Journal of Case Reports 2017; 18:926-930. PubMed Case report
- Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacology & Therapeutics 2006;109(3):325-338. PubMed Review article
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product exercise caution while driving or using machinery, as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (1)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollings CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses (excluding weight management).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Weight management.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Condition of application: Healthy mood balance; Fibromyalgia symptoms.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a psychological disorder such as anxiety or depression.
Contraindications
Condition of application: All uses.
Do not use if you have scleroderma (Lampert et al. 1992; Sternberg et al. 1980).
Sources cited by Health Canada (2)
- Lampert A, Joly P, Thomine E, Ortoli JC, Lauret P. [Scleroderma-like syndrome with bullous morphea during treatment with 5-hydroxytryptophan, carbidopa and flunitrazepam]. Annales de Dermatologie et de Vénéréologie 1992;119(3):209-211 (in French). PubMed Case report
- Sternberg EM, Van Woert MH, Young SN, Magnussen I, Baker H, Gauthier S, Osterland CK. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. New England Journal of Medicine 1980;303(14):782-787. PubMed Clinical trial
Do not use if you are taking antidepressants (Mayo Clinic Staff 2022; Patel and Marzella 2017).
Sources cited by Health Canada (2)
- Mayo Clinic Staff. Serotonin Syndrome. Rochester (MN): Mayo Foundation for Medical Education and Research; 2022. [Accessed 2023 March 07]. Available from: https://www.mayoclinic.org/diseases-conditions/serotonin-syndrome/symptoms-causes/syc-20354758.
- Patel YA, Marzella N. Dietary supplement-drug interaction-induced serotonin syndrome progressing to acute compartment syndrome. American Journal of Case Reports 2017; 18:926-930. PubMed Case report
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Weight management.
Do not use if you are pregnant (HC 2010).
Sources cited by Health Canada (2)
- HC 2010: Health Canada: Prenatal Nutrition Guidelines for health Professionals: Gestational weight gain [Accessed 2024 April 7]. Available from: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-eng.pdf
- SC 2010 : Santé Canada : Lignes directrices sur la nutrition pendant la grossesse à l'intention des professionnels de la santé : Gain de poids pendant la grossesse. [Consulté le 7 avril 2024]. Disponible à : https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-fra.pdf
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Turner et al. 2006; Byerley et al. 1987).
Sources cited by Health Canada (2)
- Byerley WF, Judd LL, Reimherr FW, Grosser BI. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects. Journal of Clinical Psychopharmacology 1987;7(3):127-137. PubMed Clinical trial
- Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacology & Therapeutics 2006;109(3):325-338. PubMed Review article
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience skin hardening, pain or stiffness of muscles or joints, tremors, agitation/confusion, or an increased heart rate (Boyer 2023; Varga 2023; Mayo Clinic Staff 2022; Patel and Marzella 2017; Das et al. 2004; Erner et al. 2003; Lampert et al. 1992; Sternberg et al. 1980).
Sources cited by Health Canada (8)
- Boyer EW. Serotonin syndrome (serotonin toxicity). UpToDate 2023 [Accessed 2023 October 18]. Available from: Available from : https://www.uptodate.com/.
- Das YT, Bagchi M, Bagchi D, Preuss HG. Safety of 5-hydroxy-L-tryptophan. Toxicology Letters 2004;150(1):111-122. PubMed Case report
- Erner RA, Meglathery SB, Van Decker WA, Gallagher RM. Serotonin Syndrome and Other Serotonergic Disorders. Pain Medicine 2003;4(1): 63-74.
- Lampert A, Joly P, Thomine E, Ortoli JC, Lauret P. [Scleroderma-like syndrome with bullous morphea during treatment with 5-hydroxytryptophan, carbidopa and flunitrazepam]. Annales de Dermatologie et de Vénéréologie 1992;119(3):209-211 (in French). PubMed Case report
- Mayo Clinic Staff. Serotonin Syndrome. Rochester (MN): Mayo Foundation for Medical Education and Research; 2022. [Accessed 2023 March 07]. Available from: https://www.mayoclinic.org/diseases-conditions/serotonin-syndrome/symptoms-causes/syc-20354758.
- Patel YA, Marzella N. Dietary supplement-drug interaction-induced serotonin syndrome progressing to acute compartment syndrome. American Journal of Case Reports 2017; 18:926-930. PubMed Case report
- Sternberg EM, Van Woert MH, Young SN, Magnussen I, Baker H, Gauthier S, Osterland CK. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. New England Journal of Medicine 1980;303(14):782-787. PubMed Clinical trial
- Varga J. Clinical manifestations and diagnosis of systemic sclerosis (scleroderma) in adults. UpToDate 2023 [Accessed 2023 October 18]. Available from : https://www.uptodate.com/.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : NaturesPlus
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Advanced Therapeutics SynaptaLean Rx-Fat Loss (NaturesPlus): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/97467049901-advanced-therapeutics-synaptalean-rx-fat-loss-naturesplus, updated 24 October 2023.